Potential role of microRNAs in the treatment and diagnosis of cervical cancer

Invasive cervical cancer (ICC) is induced by high-risk human papillomavirus (HPV) and it involves the transformation of the normal cervical epithelium to a preneoplastic cervical (1). It is the fourth most common cancer in women worldwide accounts for 528,000 new cases and 266,000 deaths each year (2). Most cervical cancer patients receive standard radiotherapy and chemotherapy. Only a few people receive the vaccines although effective prophylactic vaccines against the most important carcinogenic HPV types are available (3).

Source: Cancer Genetics and Cytogenetics - September 20, 2020 Category: Genetics & Stem Cells Authors: Shuna Shen, Shengbin Zhang, Ping Liu, Junfei Wang, Haiyan Du Source Type: research